Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) share price
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE.NS) last traded at INR 103.99, down 3.48% on the day (quote 2026-11-08 09:59 UTC), with a market cap of INR 216.3 Cr and a 52-week range of INR 97.59 to INR 147.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 103.99 |
| 1-day move | -3.48% |
| 52-week range | INR 97.59 - INR 147 |
| Market cap | INR 216.3 Cr |
| From 52-week high | -29.30% |
| Volume vs average | 1.8x |
| Falling Shares risk score | 28/100 (MODERATE) |
| Country | India |
| ISIN | INE947I01017 |
Frequently asked questions
Why is Lotus Eye Hospital and Institute Limited falling today?
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE.NS) is down 3.48% at its latest quote and trades 29.3% below its 52-week high, on volume 1.8x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Lotus Eye Hospital and Institute Limited share price today?
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE.NS) last traded at INR 103.99, a -3.48% move on the day as of 2026-11-08 09:59 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Lotus Eye Hospital and Institute Limited?
Lotus Eye Hospital and Institute Limited's 52-week low is INR 97.59 and its 52-week high is INR 147; the shares trade 29.3% below the high.
What is the market cap of Lotus Eye Hospital and Institute Limited?
Lotus Eye Hospital and Institute Limited has a market capitalisation of about INR 216.3 Cr at the latest price.
What are the risks of investing in Lotus Eye Hospital and Institute Limited?
Falling Shares Intelligence rates Lotus Eye Hospital and Institute Limited 28/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com